Eric Abadie Resigns as Chair of the CHMP
Eric Abadie resigns as chair of the CHMP Dr Eric Abadie has informed the European Medicines Agency of his intention to resign as chair of the Committee for Medicinal Products for Human Use (CHMP).
Executive Director Guido Rasi has accepted his resignation with immediate effect.
Dr Tomas Salmonson, vice-chair of the CHMP, will lead the Committee in the meantime to ensure continuity of operations.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
